Arch Mal Coeur Vaiss
November 1995
Forty years after the first implantation of caval filters, there is still no indication for implantation validated by a controlled clinical trial. This fact may be explained by our poor understanding of the evolution of thromboembolic disease, especially in certain groups of patients. The absolute contra-indications to heparin therapy would seem to be a logical indication for a caval filter.
View Article and Find Full Text PDFComplete spontaneous rupture of a percutaneous caval filter produced two equal parts. Long-term follow-up showed that the filter then remained stable with no complications. This case emphasizes the importance of long-term follow-up of patients with caval filters.
View Article and Find Full Text PDF